DorsaVi (ASX:DVL) is Combining the Best of 3 Worlds for Tomorrow’s Edge AI Devices
Silicon With a Brain DorsaVi’s (ASX:DVL) Resistive Random Access Memory (ReRAM) development is progressing toward integration at the 22nm (nanometer)…
Should the ASX be threatened by Cboe Australia? And will a potential SGX takeover make a difference?
Many investors may not have heard of Cboe Australia, or even known what it does. That all may be about…
Compelled takeovers: Here are 6 ASX companies that had no choice but to sell out
Sometimes, M&A deals occur that could be described as compelled takeovers. By this term, we are not alluding to the…
FireFly Metals Falls on A$139M Raise: Is the Dip a Buying Opportunity?
Capital Raise to Fund Aggressive Drilling FireFly Metals (ASX: FFM) shares pulled back this week after the company announced a…
Mayne Pharma (ASX: MYX) Threatens to Terminate A$672M Cosette Deal- Is the Stock a Buy at A$3.39?
The tables have turned, and shareholders face a key decision as the 10 December deadline approaches. Mayne Pharma (ASX: MYX)…
Nuix (ASX: NXL) Acquires Linkurious for $35M to Boost Graph-Powered AI Capabilities
Nuix bets on graph intelligence to rebuild investor confidence after a tough year. Nuix (ASX: NXL) has agreed to acquire…
Copper Surges 30% YTD to Record Highs: Here Are 5 ASX Stocks Positioned for the Rally
With copper up 30% this year and supply struggling to keep pace, we break down which ASX stocks offer the…
Vulcan Energy (ASX: VUL) Taps Markets for $1B, But at a Heavy Discount
Vulcan’s $1B Raise Comes at a 34% Discount Vulcan (ASX: VUL) announced today that it has completed its institutional placement…
Step One (ASX: STP) Shares Plunge 35% on Profit Warning! Is it Back to Square One?
Step One Falls Flat Step One (ASX: STP) experienced a heavy re-rating today, falling 35% in a single session. That…
Argenica (ASX: AGN) Jumps 22% as ARG-007 Clears Critical FDA Hurdle
Argenica’s ARG-007 Clears the Way Argenica Therapeutics (ASX: AGN) surged 22% today after confirming that its tenecteplase drug interaction study…
Woodside Energy (ASX: WDS): Oil and gas aren’t dead just yet, but where does this energy giant’s future lie
Woodside Energy (ASX: WDS) is the ASX’s largest energy company, capped at nearly $50bn. A traditional oil and gas giant,…
Australia’s Future Fund: What does Australia’s $290bn sovereign wealth fund invest in?
Let’s take a look at Australia’s Future Fund. Specifically how it grew to A$260bn in Funds Under Management (FUM) (not…
Saluda Medical (ASX:SLD) IPO Raises $230M, but Crashes 46% on its Trading Debut
Saluda Medical (ASX:SLD) listed on Friday after raising AU$230 million at AU$2.65 per share, marking a rare bright spot in…
Optiscan Imaging (ASX: OIL) Launches Second Cancer Trial: Why This MedTech Stock Looks Like a Buy
Optiscan Imaging (ASX: OIL) has partnered with Australian Clinical Labs to launch Australia’s first-in-human head and neck cancer imaging study.…
Australian GDP in Q3 Grew 0.4% But Misses Forecasts: Why Defensive ASX Stocks Look Attractive Now
Australian GDP in Q3 shows that its economy is…complicated. Growth is stronger than last year, but the latest quarterly numbers…